Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | %Female (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cellular and Molecular Life Sciences | journal | 3.180 Q1 | 261 | 196 | 592 | 18002 | 3218 | 573 | 5.21 | 91.85 | 33.51 | |
2 | Progress in Drug Research | book series | 0.618 Q1 | 46 | 14 | 45 | 1733 | 99 | 40 | 2.00 | 123.79 | 9.52 | |
3 | Inflammation Research | journal | 0.597 Q2 | 107 | 145 | 469 | 3756 | 724 | 459 | 1.56 | 25.90 | 33.85 | |
4 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 0.586 Q2 | 12 | 0 | 17 | 0 | 32 | 17 | 1.88 | 0.00 | 0.00 | |
5 | Pharmacology | journal | 0.452 Q2 | 67 | 93 | 210 | 2827 | 314 | 203 | 1.67 | 30.40 | 35.85 | |
6 | Drugs under Experimental and Clinical Research | journal | 0.447 Q2 | 41 | 33 | 116 | 862 | 172 | 114 | 0.55 | 26.12 | 33.33 | |
7 | Skin Pharmacology and Physiology | journal | 0.438 Q2 | 86 | 66 | 145 | 1566 | 209 | 142 | 1.34 | 23.73 | 33.15 | |
8 | Chemotherapy | journal | 0.392 Q2 | 61 | 53 | 250 | 1145 | 338 | 241 | 1.26 | 21.60 | 29.78 | |
9 | International Journal of Clinical Pharmacology Research | journal | 0.341 Q2 | 32 | 16 | 45 | 391 | 67 | 45 | 0.89 | 24.44 | 32.73 | |
10 | Molecules | journal | 0.244 Q2 | 227 | 102 | 575 | 2248 | 191 | 569 | 0.35 | 22.04 | 22.02 | |
11 | Molecular Diversity | journal | 0.232 Q4 | 63 | 0 | 27 | 0 | 5 | 26 | 0.19 | 0.00 | 0.00 | |
12 | Developments in Biological Standardization | journal | 0.217 Q4 | 44 | 0 | 146 | 0 | 109 | 146 | 0.93 | 0.00 | 0.00 | |
13 | Scientia Pharmaceutica | journal | 0.206 Q2 | 54 | 38 | 110 | 724 | 37 | 109 | 0.25 | 19.05 | 31.82 | |
14 | Developments in Biologicals | journal | 0.197 Q3 | 41 | 108 | 131 | 29 | 63 | 131 | 0.48 | 0.27 | 27.69 | |
15 | AAPS PharmSciTech | journal | 0.159 Q3 | 116 | 39 | 76 | 801 | 36 | 72 | 0.47 | 20.54 | 33.05 | |
16 | Antibiotics and chemotherapy | journal | 0.150 Q3 | 8 | 0 | 18 | 0 | 10 | 18 | 0.56 | 0.00 | 0.00 | |
17 | Inflammopharmacology | journal | 0.149 Q3 | 68 | 33 | 90 | 1806 | 35 | 90 | 0.40 | 54.73 | 16.88 | |
18 | Therapiewoche Schweiz | journal | 0.100 Q4 | 1 | 0 | 46 | 0 | 0 | 44 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®